These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. AIB1 promotes DNA replication by JNK repression and AKT activation during cellular stress. Horiguchi K; Arai S; Nishihara T; Nishikawa J J Biochem; 2006 Sep; 140(3):409-19. PubMed ID: 16877447 [TBL] [Abstract][Full Text] [Related]
31. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796 [TBL] [Abstract][Full Text] [Related]
32. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer. Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904 [TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745 [TBL] [Abstract][Full Text] [Related]
34. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Tanner MM; Tirkkonen M; Kallioniemi A; Holli K; Collins C; Kowbel D; Gray JW; Kallioniemi OP; Isola J Clin Cancer Res; 1995 Dec; 1(12):1455-61. PubMed ID: 9815944 [TBL] [Abstract][Full Text] [Related]
35. Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. Fleming FJ; Myers E; Kelly G; Crotty TB; McDermott EW; O'Higgins NJ; Hill AD; Young LS J Clin Pathol; 2004 Oct; 57(10):1069-74. PubMed ID: 15452162 [TBL] [Abstract][Full Text] [Related]
36. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656 [TBL] [Abstract][Full Text] [Related]
37. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study. Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920 [TBL] [Abstract][Full Text] [Related]
38. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347 [TBL] [Abstract][Full Text] [Related]
39. Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Glaeser M; Floetotto T; Hanstein B; Beckmann MW; Niederacher D Horm Metab Res; 2001 Mar; 33(3):121-6. PubMed ID: 11355743 [TBL] [Abstract][Full Text] [Related]
40. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. Ishikawa T; Kobayashi M; Mai M; Suzuki T; Ooi A Am J Pathol; 1997 Sep; 151(3):761-8. PubMed ID: 9284825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]